Senior Manager, Contract Assessment and Development - Alnylam Pharmaceuticals, Inc

Overview 

Reporting to the Associate Director, Contracting Analytics, in the Market Access group, this role will support contracting initiatives, pricing, and financial analytics across the company portfolio of products. This individual will provide support on all new agreements, language negotiations and contract renewals and serve as the contract subject matter expert. Additionally, this position will work to create and execute contracts and/or amendments, and maintain all contracting duties. This role will require strong cross-functional collaboration on all activities to ensure organizational alignment. This person should be familiar with and able to discuss different segments of market access, contracting strategies and tactics, understand the various types of managed care contracting and be able to determine the potential value of a contracting opportunity.

Key Responsibilities

• Management of the Contract Lifecycle, including but not limited to drafting, modification, execution, amendments, and renewal of Health Plan Value Based Agreement (VBA) contracts, IDN and GPO contracts, and Government contracts (i.e. Medicaid, VA , DoD) across a portfolio of products.
• Understand contracting strategies and maintain current knowledge supporting data structures, business processes, and documentation for assigned accounts; assist with any decisions and changes required to adapt to business needs.
• In collaboration with National Account Leads, Field Reimbursement Directors, and Health System Directors, negotiate various types of agreements.
• Ensure timely review, approval, implementation and follow-through of assigned contract proposals.
• Establish cross-functional collaboration with internal stakeholders including Legal, Pricing and Strategy, Government Pricing, and Finance to ensure agreements are operational, functional, and interpreted accurately for timely implementation and compliance with contractual obligations.
• Establish and maintain policies and applicable documentation in accordance with established departmental guidelines to support SoX compliance.
• Act as liaison between Alnylam Market Access and third-party data aggregator by applying expert knowledge of existing processes, contract terms interpretation, dashboard metrics and driving process improvements.
• Able to manage multiple projects concurrently and maintain organization among various projects and work streams.
• Develop external and internal working partnerships with collaboration across Brands, Market Access, Finance, Contracting Operations, Legal, Procurement and other functional teams in support of contracting process, strategies and offer development.

Qualifications

·      Bachelor’s degree is required, advanced degree preferred.

·      Minimum 5+ year’s relevant experience in the pharmaceutical industry including at least 3 years in pharmaceutical contracting, rebates, or finance.

·      Experience should include strong understanding of Managed Care, Medicare Part B, GPO, PBM and other Payer segments.

·      Excellent analytical, strategic thinking and critical thinking skills with the ability to translate data into strategy.

·      Understanding of key Payer and customer segments relevant to brand products and the US Reimbursement System across major Payer segments (Managed Care, Medicare, Medicaid, Federal).

·      Able to identify, develop, and recommend process improvements, drive for efficiency, innovation, and differentiation.

·      Experience influencing senior leadership and present recommendations for approval and obtaining support to execute.

·      Competent with PowerPoint, Excel, Word, etc. 

About Alnylam

Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. 

Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.